Literature DB >> 23807362

Association between microRNA polymorphisms and humoral immunity to hepatitis B vaccine.

Yongzhen Xiong1, Shengli Chen, Ruhong Chen, Weiyan Lin, Jindong Ni.   

Abstract

To investigate whether selected single nucleotide polymorphisms (SNPs) in miR-146a, miR-196a2, miR-27a, miR-26a-1, miR-124 and miR-149 genes are associated with immune response to hepatitis B vaccine. The genotype and allele frequencies of SNPs were compared between the non-responders (n=77) and responders (n=207). The associations of the genotypes with antibody levels were assessed in the responders. Significant associations were observed between SNPs in miR-146a and miR-26a-1 genes and non-response to hepatitis B vaccine (p<0.05). In addition, SNPs in miR-146a and miR-27a genes were associated with variations in levels of antibodies to hepatitis B antigen. Thus, specific SNPs in microRNAs (miRNAs) genes may affect status of the hepatitis B vaccine induced protective humoral immune response. They also suggest that the three miRNAs play a role in modulating antibody responses to hepatitis B vaccine.

Entities:  

Keywords:  antibody; hepatitis B vaccine; immune response; miRNA; polymorphisms

Mesh:

Substances:

Year:  2013        PMID: 23807362      PMCID: PMC3906264          DOI: 10.4161/hv.24938

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  28 in total

Review 1.  Hepatitis B immunization: vaccine types, efficacy, and indications for immunization.

Authors:  S C Hadler; H S Margolis
Journal:  Curr Clin Top Infect Dis       Date:  1992

2.  Immunisation against hepatitis B.

Authors: 
Journal:  Lancet       Date:  1988-04-16       Impact factor: 79.321

Review 3.  Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination.

Authors:  Maria H Sjogren
Journal:  Am J Med       Date:  2005-10       Impact factor: 4.965

4.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

5.  Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers.

Authors:  R C Wood; K L MacDonald; K E White; C W Hedberg; M Hanson; M T Osterholm
Journal:  JAMA       Date:  1993 Dec 22-29       Impact factor: 56.272

6.  Regulation of the germinal center response by microRNA-155.

Authors:  To-Ha Thai; Dinis Pedro Calado; Stefano Casola; K Mark Ansel; Changchun Xiao; Yingzi Xue; Andrew Murphy; David Frendewey; David Valenzuela; Jeffery L Kutok; Marc Schmidt-Supprian; Nikolaus Rajewsky; George Yancopoulos; Anjana Rao; Klaus Rajewsky
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

7.  [A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old].

Authors:  Xiao-feng Liang; Yuan-sheng Chen; Xiao-jun Wang; Xiong He; Li-juan Chen; Jun Wang; Chang-ying Lin; Hu-qun Bai; Jun Yan; Gang Cui; Jing-jin Yu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2005-09

Review 8.  Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations.

Authors:  F B Hollinger
Journal:  Am J Med       Date:  1989-09-04       Impact factor: 4.965

9.  MicroRNA profiling of the murine hematopoietic system.

Authors:  Silvia Monticelli; K Mark Ansel; Changchun Xiao; Nicholas D Socci; Anna M Krichevsky; To-Ha Thai; Nikolaus Rajewsky; Debora S Marks; Chris Sander; Klaus Rajewsky; Anjana Rao; Kenneth S Kosik
Journal:  Genome Biol       Date:  2005-08-01       Impact factor: 13.583

10.  A role for Dicer in immune regulation.

Authors:  Bradley S Cobb; Arnulf Hertweck; James Smith; Eric O'Connor; Daniel Graf; Terence Cook; Stephen T Smale; Shimon Sakaguchi; Frederick J Livesey; Amanda G Fisher; Matthias Merkenschlager
Journal:  J Exp Med       Date:  2006-10-23       Impact factor: 14.307

View more
  4 in total

1.  Qian Five Rhinoceros Gindeng (QFRG) protects against development of immune thrombocytopenia via miR-181a inhibition of TLR-4 expression.

Authors:  Yu-Zhou He; Ru-Feng Lu; Chen Zhu; Jun-Yi Hua
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Next-generation sequencing analysis of the human T-cell and B-cell receptor repertoire diversity before and after hepatitis B vaccination.

Authors:  Akio Miyasaka; Yuichi Yoshida; Ting Wang; Yasuhiro Takikawa
Journal:  Hum Vaccin Immunother       Date:  2019-07-25       Impact factor: 3.452

3.  The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer.

Authors:  Zhao-Lei Zeng; Jia-Huan Lu; Yun Wang; Hui Sheng; Ying-Nan Wang; Zhan-Hong Chen; Qi-Nian Wu; Jia-Bo Zheng; Yan-Xing Chen; Dong-Dong Yang; Kai Yu; Hai-Yu Mo; Jia-Jia Hu; Pei-Shan Hu; Ze-Xian Liu; Huai-Qiang Ju; Rui-Hua Xu
Journal:  Cancer Med       Date:  2021-03-05       Impact factor: 4.452

4.  Association between risk of brucellosis and genetic variations in MicroRNA-146a.

Authors:  Sima Kazemi; Saeid Afshar; Manoochehr Karami; Massoud Saidijam; Fariba Keramat; Seyed Hamid Hashemi; Mohammad Yousef Alikhani
Journal:  BMC Infect Dis       Date:  2021-10-16       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.